Clinical Trial Update: Short Versus Extended Antibiotic Treatment With a Carbapenem for High-risk Febrile Neutropenia in Hematology Patients With FUO [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial compared short versus extended antibiotic treatment with a carbapenem for high-risk febrile neutropenia in hematology patients with fev…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia
• Hematological Malignancy

Drugs mentioned

• Carbapenem (carbapenem)

Snippet

Sponsor: Amsterdam UMC, location VUmc | Conditions: Febrile Neutropenia, Hematological Malignancy | Phase 4 | Status: COMPLETED